Financial statements Magnapharm Poland
Cash flow statement of Magnapharm Poland
Company age:
Age:
21 y. 6 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of MAGNAPHARM POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 816,70 | 7 752,82 | -3 351 000,00 | -21 509 470,62 | -18 909 446,94 | 28 286 972,21 |
| Net cash flow from investing activities | -1 575,00 | -1 836,56 | -200 360,00 | -229 056,09 | -894 020,58 | 655 111,08 |
| Net cash flow from financial activities | - | -2 785,47 | 6 883 280,00 | 12 901 238,74 | 28 961 604,04 | -38 294 472,88 |
| Total net cash flow | 2 417,20 | 3 130,78 | 3 331 920,00 | -8 837 287,97 | 9 158 136,52 | -9 352 389,59 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.